{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T13:32:28Z","timestamp":1787923948078,"version":"build-2784847793"},"reference-count":32,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Cardiovasc. Dev. Dis.","JCDD"],"abstract":"<jats:p>Background: Residual arrhythmic risk persists in recipients of implantable cardioverter-defibrillators (ICDs) despite guideline-based selection, and inexpensive markers that refine this risk are needed. The monocyte-to-high-density-lipoprotein ratio (MHR) integrates a pro-inflammatory (monocyte) and an anti-inflammatory\/antioxidant (HDL) signal in a single index derived from routine blood work. We examined whether MHR is associated with ventricular arrhythmia in ICD patients. Methods: In this cross-sectional study we assessed 382 ICD recipients attending a device outpatient clinic and classified them by a composite ventricular arrhythmia outcome (non-sustained ventricular tachycardia, sustained ventricular tachycardia, or ventricular fibrillation) documented on device interrogation. MHR and comparator inflammatory markers were measured at the same visit. Discrimination was assessed by receiver operating characteristic (ROC) analysis, the optimal threshold by the Youden index, and independence by multivariable logistic regression; internal validity was examined with repeated cross-validation, bootstrap optimism correction, and calibration testing. Results: The ventricular arrhythmia outcome was present in 58 patients (15.2%). MHR was higher in patients with the outcome (median 16.3 vs. 12.3, p &lt; 0.001) and discriminated it with an area under the curve (AUC) of 0.756 (95% CI 0.673\u20130.828). At the optimal threshold of 15.71, sensitivity was 63.8% and specificity was 83.3%, with a negative predictive value of 92.8%; the outcome was present in 40.7% of patients above versus 7.2% below this cut-off. MHR remained independently associated with the outcome after adjustment for age, left ventricular ejection fraction, etiology, and renal function (odds ratio 1.23 per unit, 95% CI 1.16\u20131.32; p &lt; 0.001) and outperformed high-sensitivity C-reactive protein (DeLong p &lt; 0.001). Discrimination was preserved in both ischaemic and non-ischaemic cardiomyopathy without interaction by etiology (p = 0.67). The model was stable on internal validation (cross-validated AUC 0.761; optimism 0.021; Hosmer\u2013Lemeshow p = 0.66). Conclusions: MHR is independently associated with documented ventricular arrhythmia in ICD patients and, being derived from routine tests, may warrant prospective evaluation as a low-cost adjunct for risk stratification.<\/jats:p>","DOI":"10.3390\/jcdd13090420","type":"journal-article","created":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T12:27:46Z","timestamp":1787920066000},"page":"420","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Monocyte-to-High-Density-Lipoprotein Ratio Is Associated with Ventricular Arrhythmia in Patients with Implantable Cardioverter-Defibrillators: A Cross-Sectional Study"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7846-6391","authenticated-orcid":false,"given":"Murat","family":"K\u00fc\u00e7\u00fckukur","sequence":"first","affiliation":[{"name":"Department of Cardiology, \u0130zmir City Hospital, \u0130zmir 35530, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"}]},{"given":"Cenk","family":"Ekmek\u00e7i","sequence":"additional","affiliation":[{"name":"Department of Cardiology, \u0130zmir City Hospital, \u0130zmir 35530, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"},{"role":"visualization","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1093\/eurheartj\/ehac262","article-title":"2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death","volume":"43","author":"Zeppenfeld","year":"2022","journal-title":"Eur. Heart J."},{"key":"ref_2","first-page":"E210","article-title":"2017 AHA\/ACC\/HRS Guideline for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary","volume":"138","author":"Stevenson","year":"2018","journal-title":"Circulation"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa013474","article-title":"Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction","volume":"346","author":"Moss","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa043399","article-title":"Amiodarone or an Implantable Cardioverter\u2013Defibrillator for Congestive Heart Failure","volume":"352","author":"Bardy","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMoa1608029","article-title":"Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure","volume":"375","author":"Thune","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1056\/NEJMoa071098","article-title":"Prognostic Importance of Defibrillator Shocks in Patients with Heart Failure","volume":"359","author":"Poole","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Shomanova, Z., Ohnewein, B., Schernthaner, C., H\u00f6fer, K., Pogoda, C.A., Frommeyer, G., Wernly, B., Brandt, M.C., Dieplinger, A.-M., and Reinecke, H. (2020). Classic and Novel Biomarkers as Potential Predictors of Ventricular Arrhythmias and Sudden Cardiac Death. J. Clin. Med., 9.","DOI":"10.3390\/jcm9020578"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s42444-024-00110-z","article-title":"Inflammation and arrhythmogenesis: A narrative review of the complex relationship","volume":"25","author":"Taghdiri","year":"2024","journal-title":"Int. J. Arrhythmia"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.yjmcc.2015.11.015","article-title":"Monocyte and macrophage contributions to cardiac remodeling","volume":"93","author":"Hulsmans","year":"2016","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1093\/cvr\/cvz336","article-title":"Cardiac monocytes and macrophages after myocardial infarction","volume":"116","author":"Peet","year":"2021","journal-title":"Cardiovasc. Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/s41569-022-00823-5","article-title":"Macrophages in cardiac remodelling after myocardial infarction","volume":"20","author":"Yap","year":"2023","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1161\/01.RES.0000146094.59640.13","article-title":"Antiinflammatory properties of HDL","volume":"95","author":"Barter","year":"2004","journal-title":"Circ. Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/bph.12174","article-title":"HDL and endothelial protection","volume":"169","author":"Diallo","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Soran, H., Schofield, J.D., and Durrington, P.N. (2015). Antioxidant properties of HDL. Front. Pharmacol., 6.","DOI":"10.3389\/fphar.2015.00222"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1007\/s11255-014-0730-1","article-title":"Monocyte count\/HDL cholesterol ratio and cardiovascular events in patients with chronic kidney disease","volume":"46","author":"Kanbay","year":"2014","journal-title":"Int. Urol. Nephrol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"9237","DOI":"10.1002\/jcp.27028","article-title":"Monocyte-to-HDL-cholesterol ratio as a prognostic marker in cardiovascular diseases","volume":"233","author":"Ganjali","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1186\/s12944-025-02755-8","article-title":"Monocyte-to-HDL ratio (MHR) as a novel biomarker: Reference ranges and associations with inflammatory diseases and disease-specific mortality","volume":"24","author":"Arabi","year":"2025","journal-title":"Lipids Health Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.hlc.2016.02.023","article-title":"Monocyte to HDL Cholesterol Ratio Predicts Coronary Artery Disease Severity and Future Major Cardiovascular Adverse Events in Acute Coronary Syndrome","volume":"25","author":"Cetin","year":"2016","journal-title":"Hear. Lung Circ."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.ajem.2016.05.031","article-title":"The relation between monocyte to HDL ratio and no-reflow phenomenon in the patients with acute ST-segment elevation myocardial infarction","volume":"34","author":"Balta","year":"2016","journal-title":"Am. J. Emerg. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12944-020-01242-6","article-title":"Monocyte to High-Density Lipoprotein Ratio (MHR) as a predictor of mortality and Major Adverse Cardiovascular Events (MACE) among ST Elevation Myocardial Infarction (STEMI) patients undergoing primary percutaneous coronary intervention: A meta-analysis","volume":"19","author":"Villanueva","year":"2020","journal-title":"Lipids Health Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s12944-019-1116-2","article-title":"Monocyte to high-density lipoprotein cholesterol ratio as long-term prognostic marker in patients with coronary artery disease undergoing percutaneous coronary intervention","volume":"18","author":"Wu","year":"2019","journal-title":"Lipids Health Dis."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Pei, G., Liu, R., Wang, L., He, C., Fu, C., and Wei, Q. (2023). Monocyte to high-density lipoprotein ratio is associated with mortality in patients with coronary artery diseases. BMC Cardiovasc. Disord., 23.","DOI":"10.1186\/s12872-023-03461-y"},{"key":"ref_23","first-page":"1807","article-title":"The role of preprocedural monocyte-to-high-density lipoprotein ratio in prediction of atrial fibrillation recurrence after cryoballoon-based catheter ablation","volume":"17","author":"Canpolat","year":"2015","journal-title":"Eur."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Chen, S.-A., Zhang, M.-M., Zheng, M., Liu, F., Sun, L., Bao, Z.-Y., Chen, F.-K., Li, H.-X., and Gu, X. (2020). The preablation monocyte\/ high density lipoprotein ratio predicts the late recurrence of paroxysmal atrial fibrillation after radiofrequency ablation. BMC Cardiovasc. Disord., 20.","DOI":"10.1186\/s12872-020-01670-3"},{"key":"ref_25","first-page":"96","article-title":"Role of the monocyte-to-high-density lipoprotein ratio in predicting atrial high-rate episodes detected by cardiac implantable electronic devices","volume":"5","author":"Satilmis","year":"2018","journal-title":"North. Clin. Istanb."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1186\/s40001-023-01451-6","article-title":"Monocyte to high-density lipoprotein cholesterol ratio predicts poor outcomes in ischaemic heart failure patients combined with diabetes: A retrospective study","volume":"28","author":"Li","year":"2023","journal-title":"Eur. J. Med. Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s12944-022-01742-7","article-title":"The monocyte to high-density lipoprotein cholesterol ratio is a risk factor for frequent premature ventricular complexes: A retrospective cohort study","volume":"21","author":"Wang","year":"2022","journal-title":"Lipids Health Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/pace.13003","article-title":"The Neutrophil-to-Lymphocyte Ratio Predicts All-Cause Mortality in Patients with Implantable Cardioverter Defibrillators","volume":"40","author":"Hashimoto","year":"2016","journal-title":"Pacing Clin. Electrophysiol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1093\/eurheartj\/ehr487","article-title":"Risk stratification of ischaemic patients with implantable cardioverter defibrillators by C-reactive protein and a multi-markers strategy: Results of the CAMI-GUIDE study","volume":"33","author":"Biasucci","year":"2012","journal-title":"Eur. Hear. J."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"5152","DOI":"10.1038\/s41598-018-22868-8","article-title":"Higher High-Sensitivity C Reactive Protein is Associated with Future Premature Ventricular Contraction: A Community Based Prospective Cohort Study","volume":"8","author":"Chen","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.hrthm.2015.01.007","article-title":"Magnetic resonance estimates of the extent and heterogeneity of scar tissue in ICD patients with ischemic cardiomyopathy predict ventricular arrhythmia","volume":"12","author":"Yang","year":"2015","journal-title":"Heart Rhythm"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.jacc.2024.06.046","article-title":"Arrhythmic Risk Stratification by Cardiovascular Magnetic Resonance Imaging in Patients with Nonischemic Cardiomyopathy","volume":"84","author":"Hammersley","year":"2024","journal-title":"JACC"}],"container-title":["Journal of Cardiovascular Development and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2308-3425\/13\/9\/420\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T13:02:38Z","timestamp":1787922158000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2308-3425\/13\/9\/420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,28]]},"references-count":32,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["jcdd13090420"],"URL":"https:\/\/doi.org\/10.3390\/jcdd13090420","relation":{},"ISSN":["2308-3425"],"issn-type":[{"value":"2308-3425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,28]]}}}